CLT Research & Evidence Base 3 — Questions and Answers
Question 1: Which specific evidence-based outcome did Amador's 2007 controlled study emphasize as the primary benefit of using LEAP with patients with schizophrenia?
- Reduced psychotic symptom frequency
- Improved therapeutic alliance leading to better adherence (Correct answer)
- Faster discharge from inpatient units
- Decreased family caregiver burden
Correct answer: Improved therapeutic alliance leading to better adherence
Amador's research focused on improved therapeutic alliance as the mechanism by which LEAP reduced nonadherence, not direct symptom change.
Question 2: In research measuring the LEAP effect on family members using the approach, which outcome showed statistically significant improvement?
- Reduction in expressed emotion
- Increased patient insight scores
- Greater willingness by the patient to seek outpatient care (Correct answer)
- Decreased police contact incidents
Correct answer: Greater willingness by the patient to seek outpatient care
Studies involving family-delivered LEAP found the strongest effect on patients' willingness to engage with outpatient treatment, not direct insight change.
Question 3: Evidence-based practice guidelines recommend LEAP most strongly for which clinical population?
- High-functioning adults with mild anxiety
- Individuals with psychotic disorders and anosognosia who refuse treatment (Correct answer)
- Children with ADHD and oppositional behavior
- Elderly patients with dementia
Correct answer: Individuals with psychotic disorders and anosognosia who refuse treatment
LEAP is most strongly indicated for individuals with psychotic disorders who exhibit anosognosia and resist treatment, which is the population driving its research base.
Question 4: Research on the 'Agreeing' component of LEAP shows that finding common ground with patients is clinically effective primarily because it does what?
- Validates delusional beliefs as real
- Reduces adversarial dynamics without requiring agreement on diagnosis (Correct answer)
- Convinces the patient their clinician shares their worldview
- Shortens the duration of therapy sessions
Correct answer: Reduces adversarial dynamics without requiring agreement on diagnosis
The Agreeing step reduces conflict by identifying genuine shared concerns, never requiring the clinician to endorse false illness beliefs.
Question 5: A meta-analysis of intervention studies targeting anosognosia in schizophrenia found which approach yielded the most consistent treatment engagement outcomes?
- Psychoeducation delivered in group format
- Combined motivational and relational techniques like LEAP (Correct answer)
- Cognitive remediation targeting self-monitoring
- Pharmacological insight enhancement with antipsychotics
Correct answer: Combined motivational and relational techniques like LEAP
Meta-analytic evidence supports combined motivational and relational approaches as more effective for engagement than standalone psychoeducation or cognitive remediation.
Question 6: In LEAP outcome research, which measurement time point shows the most durable medication adherence effects?
- 2 weeks post-training
- 3 months post-intervention
- 6–12 months follow-up (Correct answer)
- Immediately after first LEAP session
Correct answer: 6–12 months follow-up
Studies tracking LEAP outcomes find that adherence gains are most durable and clinically meaningful at 6–12 month follow-up assessments.
Question 7: Research into the 'Listening' phase of LEAP found that open-ended reflection without argumentation reduced which specific patient behavior?
- Flat affect during sessions
- Defensive resistance and hostility toward treatment (Correct answer)
- Cognitive disorganization in speech
- Grandiose delusion frequency
Correct answer: Defensive resistance and hostility toward treatment
Non-confrontational listening directly reduces defensive resistance and hostility, creating the relational conditions necessary for later partnership steps.
Which specific evidence-based outcome did Amador's 2007 controlled study emphasize as the primary benefit of using LEAP with patients with schizophrenia?